HT Simonsen Holding ApS: Financial statements 2023
CVR: 37334308
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HT Simonsen Holding ApS (CVR 37334308) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 5,202 and a net result of DKK 5,202 compared with DKK -10,040 the year before. The profit margin was 100%. Equity in the 2023 report amounted to DKK 22,564. The solvency ratio was 100%.
- Revenue
- DKK 5,202
- Gross Profit
- DKK 202
- Profit/Loss
- DKK 5,202
- Equity
- DKK 22,564
- Total Assets
- DKK 22,564
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 5 t. | 202 | 5 t. | 23 t. | - |
| 2022 | 0 | -10 t. | -10 t. | 31 t. | - |
| 2021 | - | -2 t. | 13 t. | 48 t. | - |
| 2020 | - | -30 t. | -30 t. | 2 t. | - |
| 2019 | 0 | 0 | 0 | 32 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HT Simonsen Holding ApS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK -10,040.
About HT Simonsen Holding ApS
HT Simonsen Holding ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named HT Simonsen Holding IVS and Mosspiration Biotech IVS. The management consists of Henrik Toft Simonsen. The company is owned by Henrik Toft Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -990 and a net result of DKK -990 compared with DKK -477 the year before. Equity in the 2025 report amounted to DKK 12,465.